PCM
EMN icon

Portolan Capital Management’s Eastman Chemical EMN Stock Holding History

Portolan Capital Management’s Portfolio EMN Stock Details EMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-47,726
Closed -$3.86M – 123
2017
Q1 		$3.86M Buy
+47,726
New +$3.75M 0.5% 75

Other funds holding EMN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Portolan Capital Management's EMN Position: Q2 2017 in Review

Portolan Capital Management sold out of Eastman Chemical (EMN) in Q2 2017, closing a stake of 47,726 shares — an estimated $3.86M sold.

Portolan Capital Management first reported a position in EMN in Q1 2017 and held it in 1 quarter. The position peaked at $3.86M in Q1 2017. 618 funds tracked by Wall St. Rank hold EMN as of Q2 2017.

  • Portolan Capital Management reported no remaining Eastman Chemical position as of Q2 2017 after selling out during the quarter.
  • Portolan Capital Management sold 47,726 Eastman Chemical shares in Q2 2017, an estimated $3.86M.
  • Portolan Capital Management first reported a position in Eastman Chemical in Q1 2017 and held it in 1 quarter.
  • Portolan Capital Management's Eastman Chemical position peaked at $3.86M in Q1 2017.
  • 618 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2017.

Based on Portolan Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.